This educational program is targeted at healthcare providers who treat NASH.
This initiative will provide education on emerging advances in research and expert recommendations in the management of veteran patients with NASH.
Upon completion of this educational activity, participants should be able to:
Describe the pathogenesis and natural history of NAFLD/NASH and the impact on fibrosis outcomes
Describe current recommendations or guidelines related to screening and diagnosis of NASH
Effectively incorporate the current standard of care/guidelines for diagnosis and management of NAFLD/NASH into clinical practice
Discuss the benefits and limitations of current diagnostic modalities and treatment options for NAFLD/NASH
Describe recent evidence regarding new and emerging noninvasive diagnostic modalities for NASH
Describe the mechanisms of action of novel agents for the treatment of NASH
Discuss recent evidence regarding the safety and efficacy of emerging agents for the treatment of NASH
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and The Chronic Liver Disease Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University College of Pharmacy designates this live activity for a maximum
of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
All additional planning committee members, staff and reviewers of The Chronic Liver Disease Foundation and Purdue University College of Pharmacy have no relationships to disclose.
Americans with Disabilities Act:
The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-888-565-5321.
This program is supported by an educational grant from Intercept Pharmaceuticals.